1. Home
  2. BIO vs MTZ Comparison

BIO vs MTZ Comparison

Compare BIO & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$300.28

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Logo MasTec Inc.

MTZ

MasTec Inc.

HOLD

Current Price

$219.75

Market Cap

17.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
MTZ
Founded
1952
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Water Sewer Pipeline Comm & Power Line Construction
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
17.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BIO
MTZ
Price
$300.28
$219.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
20
Target Price
$358.50
$231.37
AVG Volume (30 Days)
170.4K
836.8K
Earning Date
10-29-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
270.77
EPS
N/A
4.20
Revenue
$2,557,500,000.00
$13,762,473,000.00
Revenue This Year
$1.77
$15.48
Revenue Next Year
$2.30
$10.21
P/E Ratio
N/A
$51.98
Revenue Growth
N/A
12.99
52 Week Low
$211.43
$99.70
52 Week High
$373.69
$233.14

Technical Indicators

Market Signals
Indicator
BIO
MTZ
Relative Strength Index (RSI) 39.06 55.73
Support Level $298.02 $206.15
Resistance Level $307.78 $233.14
Average True Range (ATR) 8.35 8.68
MACD -2.13 -0.78
Stochastic Oscillator 16.30 49.30

Price Performance

Historical Comparison
BIO
MTZ

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.

Share on Social Networks: